PROSTATESENTRY Trademark

Trademark Overview


On Wednesday, October 24, 2012, a trademark application was filed for PROSTATESENTRY with the United States Patent and Trademark Office. The USPTO has given the PROSTATESENTRY trademark a serial number of 85762609. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 23, 2017. This trademark is owned by GeneNews Limited. The PROSTATESENTRY trademark is filed in the Medical Instrument Products category with the following description:

blood drawing apparatus; diagnostic kits; diagnostic kits comprising molecular biological reagents useful for detecting gene expression products, including ribonucleic acid (RNA) or proteins, as an indication of body state, including body health, condition, disease , response to external stimuli, or response to therapeutic treatment; diagnostic services, including diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical services, including clinical laboratory testing services, and patient triage or risk stratification services, including determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients, medical and diagnostic services, including diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testin...
prostatesentry

General Information


Serial Number85762609
Word MarkPROSTATESENTRY
Filing DateWednesday, October 24, 2012
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 23, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesblood drawing apparatus; diagnostic kits; diagnostic kits comprising molecular biological reagents useful for detecting gene expression products, including ribonucleic acid (RNA) or proteins, as an indication of body state, including body health, condition, disease , response to external stimuli, or response to therapeutic treatment; diagnostic services, including diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical services, including clinical laboratory testing services, and patient triage or risk stratification services, including determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients, medical and diagnostic services, including diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, and monitoring of patient health progression; medical and diagnostic services, namely evaluating clinical trial progress, and drug monitoring; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating treatment progression, and prognosing disease or disease progression; providing genomic, proteomic and gene expression profiles useful in evaluating the efficacy and toxicity of treatments, and identifying disease heredity risk factors; research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; computer services, including providing a website for patients and medical professionals featuring educational information about personalized health management, disease, and disease risk assessment services and screening products; computer services, including computer tracking of and providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics; computer services, including maintaining and providing access to a patient registry containing personalized health management information accessible via global, national and local computer networks
Pseudo MarkPROSTATE SENTRY

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, October 30, 2012
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGENENEWS LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressMARKHAM, ONTARIO L3R 9X7
CA

Party NameGeneNews Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRichmond Hill, Ontario L4B2N3
CA

Trademark Events


Event DateEvent Description
Monday, January 23, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 23, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 23, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 2, 2016INQUIRY AS TO SUSPENSION MAILED
Monday, May 2, 2016SUSPENSION INQUIRY WRITTEN
Tuesday, April 5, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, September 30, 2015LETTER OF SUSPENSION MAILED
Tuesday, September 29, 2015SUSPENSION LETTER WRITTEN
Tuesday, September 8, 2015LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, March 4, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 4, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 25, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 3, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 11, 2014ASSIGNED TO EXAMINER
Monday, March 3, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 26, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 25, 2013LETTER OF SUSPENSION MAILED
Monday, February 25, 2013SUSPENSION LETTER WRITTEN
Thursday, February 14, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 14, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 11, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 23, 2012NON-FINAL ACTION MAILED
Wednesday, November 21, 2012NON-FINAL ACTION WRITTEN
Friday, November 16, 2012ASSIGNED TO EXAMINER
Friday, November 16, 2012ASSIGNED TO LIE
Tuesday, November 6, 2012TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, October 31, 2012NOTICE OF PSEUDO MARK MAILED
Tuesday, October 30, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 27, 2012NEW APPLICATION ENTERED IN TRAM